Cellectar Receives USPTO Notice of Allowance for Patent Covering Use of CLR 131 in Multiple Myeloma Biotech Investing
Keryx Biopharmaceuticals Announces Fourth Quarter and Full Year 2017 Financial Results Biotech Investing
Akari Therapeutics Announces Completion of Phase II COBALT Trial of Coversin in Patients with PNH Biotech Investing
BioDelivery Sciences Announces BELBUCA® Patent Litigation Settlement Agreement with Teva Biotech Investing
Phivida Appoints Former Senior Executive Officer of Red Bull, Samsung, Microsoft as New Chief Marketing Officer Biotech Investing
Capricor Receives FDA Regenerative Medicine Advanced Therapy Designation for Duchenne Muscular Dystrophy Therapy Biotech Investing
Seegnal Inc. Receives Gold Mark from the Standards Institution of Israel, Advancing Commercialization Readiness